LARA COMPTON

Medicare and Medicaid reimbursement for digital therapeutics and guidance from CMS regarding Medicare and Medicaid reimbursement for digital therapeutics under existing benefit categories. Specifically, H.R 1458/S. 723 Access to Prescription Digital Therapeutics Act of 2023 and H.R. 8816, the American Medical Innovation and Investment Act of 2024.

Medicare and Medicaid reimbursement for digital therapeutics and guidance from CMS regarding Medicare and Medicaid reimbursement for digital therapeutics under existing benefit categories. Specifically, H.R 1458/S. 723 Access to Prescription Digital Therapeutics Act of 2023 and H.R. 8816, the American Medical Innovation and Investment Act of 2024.

Medicare and Medicaid reimbursement for digital therapeutics and guidance from CMS regarding Medicare and Medicaid reimbursement for digital therapeutics under existing benefit categories. Specifically, H.R 1458/S. 723 Access to Prescription Digital Therapeutics Act of 2023 and H.R. 8816, the American Medical Innovation and Investment Act of 2024.

Medicare and Medicaid reimbursement for digital therapeutics and guidance from CMS regarding Medicare and Medicaid reimbursement for digital therapeutics under existing benefit categories. Specifically, H.R 1458/S. 723 Access to Prescription Digital Therapeutics Act of 2023 and H.R. 8816, the American Medical Innovation and Investment Act of 2024.

H.R 1458/S. 723 Access to Prescription Digital Therapeutics Act of 2023

Medicare and Medicaid coverage for digital therapeutics. Specifically: H.R 1458/S. 723 Access to Prescription Digital Therapeutics Act of 2023. Other legislation improving access to digital therapeutics, for example, streamlining and clarifying Food and Drug Administration approval.